Wells Fargo Starts Kestra Medical Technologies (KMTS) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BofA Securities Starts Kestra Medical Technologies (KMTS) at Buy
March 31, 2025 6:52 AM EDTBofA Securities analyst Travis Steed initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Buy rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Kestra Medical Technologies... More
Wolfe Research Starts Kestra Medical Technologies (KMTS) at Outperform
March 31, 2025 5:19 AM EDTWolfe Research analyst Mike Polark initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Kestra Medical Technologies... More
Goldman Sachs Starts Kestra Medical Technologies (KMTS) at Neutral
March 31, 2025 5:12 AM EDTGoldman Sachs analyst David Roman initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Neutral rating and a price target of $24.00.
The analyst comments "We initiate coverage on the shares of Kestra Medical Technologies (KMTS) with a Neutral rating and a 12-month price target... More
Piper Sandler Starts Kestra Medical Technologies (KMTS) at Overweight
March 31, 2025 3:55 AM EDTPiper Sandler analyst Matt O\'Brien initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Overweight rating and a price target of $27.00.
The analyst comments: "We are initiating Kestra Medical with an OW rating and $27 price target. The company boasts a unique, wearable... More
Stifel Starts Kestra Medical Technologies (KMTS) at Buy
March 31, 2025 2:07 AM EDTStifel analyst Rick Wise initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Buy rating and a price target of $28.00.
The analyst comments: "We are initiating coverage of Kestra (KMTS) with a Buy rating and $28 target price. This assumes KMTS trades at 9x our CY2027E... More



